- Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
-
Alnimer L, Noureddin M
- KMID: 2541426
- Clin Mol Hepatol.
- 2023 Apr;29(2):394-397.
- doi: 10.3350/cmh.2023.0104
-
- CITED
-
- Close
- SHARE
-
- Close
- Diabetes and Risk of Hepatocellular Carcinoma in Cirrhosis Patients with Nonalcoholic Fatty Liver Disease
-
Teng PC, Huang DQ, Lin TY, Noureddin M, Yang JD
- KMID: 2538154
- Gut Liver.
- 2023 Jan;17(1):24-33.
- doi: 10.5009/gnl220357
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the world. NAFLD is a hepatic manifestation of insulin resistance, the core pathophysiology of diabetes.... -
- CITED
-
- Close
- SHARE
-
- Close
- Factors associated with unrecognized cirrhosis in patients with hepatocellular carcinoma
-
Lee YT, Karim MA, Kum HC, Park S, Rich NE, Noureddin M, Singal AG, Yang JD
- KMID: 2541435
- Clin Mol Hepatol.
- 2023 Apr;29(2):453-464.
- doi: 10.3350/cmh.2022.0450
Background/Aims: Cirrhosis is the most important risk factor of hepatocellular carcinoma (HCC), and patients with cirrhosis are recommended to receive semiannual surveillance for early HCC detection. However, early cirrhosis is... -
- CITED
-
- Close
- SHARE
-
- Close
